| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 404 | 2013 |
| Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease K Poesen, M De Schaepdryver, B Stubendorff, B Gille, P Muckova, ... Neurology 88 (24), 2302-2309, 2017 | 247 | 2017 |
| Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ... Neurology 90 (1), e22-e30, 2018 | 216 | 2018 |
| Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration K Poesen, D Lambrechts, P Van Damme, J Dhondt, F Bender, N Frank, ... Journal of Neuroscience 28 (42), 10451-10459, 2008 | 186 | 2008 |
| Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties F Bono, F De Smet, C Herbert, K De Bock, M Georgiadou, P Fons, M Tjwa, ... Cancer cell 23 (4), 477-488, 2013 | 147 | 2013 |
| Diagnostic and prognostic performance of neurofilaments in ALS K Poesen, P Van Damme Frontiers in neurology 9, 1167, 2019 | 145 | 2019 |
| Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis B Gille, M De Schaepdryver, J Goossens, L Dedeene, J De Vocht, ... Neuropathology and applied neurobiology 45 (3), 291-304, 2019 | 121 | 2019 |
| Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis M De Schaepdryver, A Jeromin, B Gille, KG Claeys, V Herbst, B Brix, ... Journal of Neurology, Neurosurgery & Psychiatry 89 (4), 367-373, 2018 | 121 | 2018 |
| Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the− 2578AA genotype D Lambrechts, K Poesen, R Fernandez-Santiago, A Al-Chalabi, R Del Bo, ... Journal of medical genetics 46 (12), 840-846, 2009 | 115* | 2009 |
| Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS P Oeckl, C Jardel, F Salachas, F Lamari, PM Andersen, R Bowser, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17 (5-6), 404-413, 2016 | 112 | 2016 |
| Altered perivascular fibroblast activity precedes ALS disease onset A Månberg, N Skene, F Sanders, M Trusohamn, J Remnestål, ... Nature medicine 27 (4), 640-646, 2021 | 104 | 2021 |
| VEGF protects motor neurons against excitotoxicity by upregulation of GluR2 E Bogaert, P Van Damme, K Poesen, J Dhondt, N Hersmus, D Kiraly, ... Neurobiology of aging 31 (12), 2185-2191, 2010 | 104 | 2010 |
| Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1 CR De Almodovar, C Coulon, PA Salin, E Knevels, N Chounlamountri, ... Journal of Neuroscience 30 (45), 15052-15066, 2010 | 94 | 2010 |
| Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? B Gille, M De Schaepdryver, L Dedeene, J Goossens, KG Claeys, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (12), 1338-1346, 2019 | 92 | 2019 |
| C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility L Fumagalli, FL Young, S Boeynaems, M De Decker, AR Mehta, ... Science advances 7 (15), eabg3013, 2021 | 91 | 2021 |
| Diagnostic challenges and clinical characteristics of hepatitis E virus–associated Guillain-Barré syndrome O Stevens, KG Claeys, K Poesen, V Saegeman, P Van Damme JAMA neurology 74 (1), 26-33, 2017 | 83 | 2017 |
| Therapeutic potential of VEGF and VEGF-derived peptide in peripheral neuropathies A Verheyen, E Peeraer, D Lambrechts, K Poesen, P Carmeliet, M Shibuya, ... Neuroscience 244, 77-89, 2013 | 80 | 2013 |
| Comparison of ELISA-and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis S De Meyer, JM Schaeverbeke, IMW Verberk, B Gille, M De Schaepdryver, ... Alzheimer's research & therapy 12, 1-16, 2020 | 78 | 2020 |
| Detection of myositis-specific antibodies JB Vulsteke, E De Langhe, KG Claeys, D Dillaerts, K Poesen, J Lenaerts, ... Annals of the rheumatic diseases 78 (1), e7-e7, 2019 | 70 | 2019 |
| Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons J Dhondt, E Peeraer, A Verheyen, R Nuydens, I Buysschaert, K Poesen, ... The FASEB Journal 25 (5), 1461, 2011 | 67 | 2011 |
Philip Van DammeProfessor of Neuroscience, University of Leuven確認したメール アドレス: uzleuven.be